Literature DB >> 27170273

Ultra-protective ventilation and hypoxemia.

Luciano Gattinoni1.   

Abstract

Partial extracorporeal CO2 removal allows a decreasing tidal volume without respiratory acidosis in patients with acute respiratory distress syndrome. This, however, may be associated with worsening hypoxemia, due to several mechanisms, such as gravitational and reabsorption atelectasis, due to a decrease in mean airway pressure and a critically low ventilation-perfusion ratio, respectively. In addition, an imbalance between alveolar and artificial lung partial pressures of nitrogen may accelerate the process. Finally, the decrease in the respiratory quotient, leading to unrecognized alveolar hypoxia and monotonous low plateau pressures preventing critical opening, may contribute to hypoxemia.

Entities:  

Mesh:

Year:  2016        PMID: 27170273      PMCID: PMC4865006          DOI: 10.1186/s13054-016-1310-9

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


The capability to remove some of the metabolically produced CO2 with artificial lungs using a low extracorporeal blood flow (<1 l/min) and a high extracorporeal gas flow provides a key to significantly reduce mechanical ventilation (the ultra-protective strategy) [1]. This, and the easily established vascular access, make the method attractive for acute respiratory distress syndrome (ARDS) patients, in whom even the standard 6 ml/kg tidal volume (TV) may still produce unacceptable stress and strain [2]. In a recent multicenter study, Fanelli et al. [1] tested the feasibility of the ultra-protective strategy in combination with extracorporeal carbon dioxide removal (ECCO2R) in 15 patients with moderate ARDS. The authors concluded that one could use ultra-protective ventilation with a TV of 4 ml/kg without resulting relevant respiratory acidosis. The price of attaining this goal, however, appears quite high. Six of the 15 patients (40 %) with initially moderate ARDS experienced life-threatening hypoxemia and required either extracorporeal membrane oxygenation (ECMO) or the prone position. The authors concluded that the impact of the ultra-protective strategy, ECCO2R, on hypoxemia is not clear. We believe, however, that the observed hypoxemia is due to well-defined mechanisms acting simultaneously, which may be summarized as follows: Gravitational atelectasis: Whenever ventilation decreases (reduction of TV and/or respiratory rate) the mean airway pressure decreases, and the lungs tend to collapse. The greater the decrease in ventilation and the greater the lung weight, the greater will be the collapse. This phenomenon, albeit to a lesser extent, occurs in normal lungs on induction of anesthesia [3]. This has been observed experimentally during ECCO2R and mechanical ventilation [4]. Positive end-expiratory pressure (PEEP) must be increased by an amount sufficient to maintain the same mean airway pressure in order to preserve the open lung volume [5] otherwise some amount of gravitational collapse is unavoidable. In the study of Fanelli et al., the PEEP increase was so low as to be non-significant. Absorption atelectasis: At least two conditions favor the appearance of absorption atelectasis. Firstly, when ventilation is very low the amount of oxygen provided to some pulmonary units may be lower than the amount removed by the blood perfusing those units. This produces a collapse of the pulmonary unit when its ventilation (VA)/perfusion (Q) ratio reaches a critical level [6]. Secondly, if the artificial lung is ventilated with a fraction of inspired oxygen (FiO2) greater than that used for the natural lung, the partial pressure of nitrogen in the blood perfusing the natural lung is lower than that in the alveoli [7]. Under these conditions the critical VA/Q is reached more rapidly, since not only oxygen but also nitrogen leaves the alveoli. In the study by Fanelli et al., the artificial lungs were ventilated with an FiO2 of 1.0 in some of the centers, while the natural lungs were ventilated with an FiO2 of 0.5. Opening pressures: Sufficient pressure must be applied to reopen the atelectatic areas. Studies show that at least one normal TV every 2 min was mandatory in order to correct or prevent atelectasis, otherwise a consistent reduction in lung volume was observed [4]. This low frequency has an effect similar to sighing [8]. In ARDS patients with a plateau pressure of 25 cmH2O, as employed in the study by Fanelli et al., we may estimate that 30 to 40 % of the recruitable lung always remains closed [9, 10]. This implies that oxygenation cannot take place even during inspiration [11], and that newly formed atelectasis cannot be reopened. Alveolar PaO2and respiratory quotient: During ECCO2R, the respiratory quotient (R) decreases when the CO2 eliminated by the natural lungs decreases. To maintain the same alveolar partial pressure of oxygen (PaO2), the FiO2 must be increased. This has been proved experimentally [12] and can be easily derived from the alveolar gas equation [13]. The lower the FiO2, the greater the impact of R on alveolar PaO2. For example, with FiO2 = 0.3, partial pressure of CO2 = 50 mmHg, and R = 1.0, PaO2 is approximately 164 mmHg. With FiO2 kept constant at 0.3, alveolar PaO2 decreases to 113 mmHg when R is reduced to 0.5 and to as low as 48 mmHg when R is decreased to 0.3. The risk of unrecognized alveolar hypoxia as the cause of hypoxemia must be kept in mind during ECCO2R, particularly if a FiO2 below 0.4 is being used. All discussed causes of hypoxemia may be prevented or corrected with the proper use of PEEP, FiO2 and recruitment maneuvers, e.g., intermittent sighs.
  13 in total

1.  Recruitment and derecruitment during acute respiratory failure: a clinical study.

Authors:  S Crotti; D Mascheroni; P Caironi; P Pelosi; G Ronzoni; M Mondino; J J Marini; L Gattinoni
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

2.  Proceedings: Instability of poorly ventilated lung units during oxygen breathing.

Authors:  D R Dantzker; P D Wagner; J B West
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

3.  Pulmonary densities during anesthesia with muscular relaxation--a proposal of atelectasis.

Authors:  B Brismar; G Hedenstierna; H Lundquist; A Strandberg; L Svensson; L Tokics
Journal:  Anesthesiology       Date:  1985-04       Impact factor: 7.892

4.  An alternative to breathing.

Authors:  T Kolobow; L Gattinoni; T Tomlinson; J E Pierce
Journal:  J Thorac Cardiovasc Surg       Date:  1978-02       Impact factor: 5.209

5.  Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPV-ECCO2R): an experimental study.

Authors:  L Gattinoni; T Kolobow; T Tomlinson; G Iapichino; M Samaja; D White; J Pierce
Journal:  Anesth Analg       Date:  1978 Jul-Aug       Impact factor: 5.108

6.  Sigh in acute respiratory distress syndrome.

Authors:  P Pelosi; P Cadringher; N Bottino; M Panigada; F Carrieri; E Riva; A Lissoni; L Gattinoni
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

7.  Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome.

Authors:  Pier Paolo Terragni; Giulio Rosboch; Andrea Tealdi; Eleonora Corno; Eleonora Menaldo; Ottavio Davini; Giovanni Gandini; Peter Herrmann; Luciana Mascia; Michel Quintel; Arthur S Slutsky; Luciano Gattinoni; V Marco Ranieri
Journal:  Am J Respir Crit Care Med       Date:  2006-10-12       Impact factor: 21.405

8.  Reversibility of lung collapse and hypoxemia in early acute respiratory distress syndrome.

Authors:  João B Borges; Valdelis N Okamoto; Gustavo F J Matos; Maria P R Caramez; Paula R Arantes; Fabio Barros; Ciro E Souza; Josué A Victorino; Robert M Kacmarek; Carmen S V Barbas; Carlos R R Carvalho; Marcelo B P Amato
Journal:  Am J Respir Crit Care Med       Date:  2006-05-11       Impact factor: 21.405

9.  Control of intermittent positive pressure breathing (IPPB) by extracorporeal removal of carbon dioxide.

Authors:  L Gattinoni; T Kolobow; T Tomlinson; D White; J Pierce
Journal:  Br J Anaesth       Date:  1978-08       Impact factor: 9.166

10.  Hemodynamic, mechanical and renal effects during "apneic oxygenation" with extracorporeal carbon dioxide removal, at different levels of intrapulmonary pressure in lambs.

Authors:  L Gattinoni; G Iapichino; T Kolobow
Journal:  Int J Artif Organs       Date:  1979-09       Impact factor: 1.595

View more
  17 in total

Review 1.  [Update: acute hypercapnic respiratory failure].

Authors:  F Seiler; F C Trudzinski; M Kredel; C Lotz; P M Lepper; R M Muellenbach
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-07-13       Impact factor: 0.840

Review 2.  [Current techniques for extracorporeal decarboxylation].

Authors:  J Nentwich; S John
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-04-24       Impact factor: 0.840

Review 3.  Tidal volume in acute respiratory distress syndrome: how best to select it.

Authors:  Michele Umbrello; Antonella Marino; Davide Chiumello
Journal:  Ann Transl Med       Date:  2017-07

4.  Do we need randomized clinical trials in extracorporeal respiratory support? No.

Authors:  Luciano Gattinoni; Michael Quintel
Journal:  Intensive Care Med       Date:  2017-09-25       Impact factor: 17.440

Review 5.  Ventilation during extracorporeal support : Why and how.

Authors:  A Pesenti; E Carlesso; T Langer; T Mauri
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-11-28       Impact factor: 0.840

6.  Benefits and risks of the P/F approach.

Authors:  L Gattinoni; F Vassalli; F Romitti
Journal:  Intensive Care Med       Date:  2018-10-23       Impact factor: 17.440

Review 7.  Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failure.

Authors:  Andrea Morelli; Lorenzo Del Sorbo; Antonio Pesenti; V Marco Ranieri; Eddy Fan
Journal:  Intensive Care Med       Date:  2017-01-28       Impact factor: 17.440

Review 8.  Fifty Years of Research in ARDS. Vt Selection in Acute Respiratory Distress Syndrome.

Authors:  Sarina K Sahetya; Jordi Mancebo; Roy G Brower
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

9.  Pharmacokinetics of anidulafungin during venovenous extracorporeal membrane oxygenation.

Authors:  Gerardo Aguilar; Rafael Ferriols; José A Carbonell; Carlos Ezquer; José Miguel Alonso; Abigail Villena; Jaume Puig; David Navarro; Manuel Alós; F Javier Belda
Journal:  Crit Care       Date:  2016-10-17       Impact factor: 9.097

10.  pRotective vEntilation with veno-venouS lung assisT in respiratory failure: A protocol for a multicentre randomised controlled trial of extracorporeal carbon dioxide removal in patients with acute hypoxaemic respiratory failure.

Authors:  J J McNamee; M A Gillies; N A Barrett; A M Agus; R Beale; A Bentley; A Bodenham; S J Brett; D Brodie; S J Finney; A J Gordon; M Griffiths; D Harrison; C Jackson; C McDowell; C McNally; G D Perkins; W Tunnicliffe; A Vuylsteke; T S Walsh; M P Wise; D Young; D F McAuley
Journal:  J Intensive Care Soc       Date:  2016-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.